Exploring Therapeutic Targets of the Beta Amyloid Pathway to Slow the Progression of Alzheimer Disease

https://www.pharmacytimes.org/on-demand/exploring-therapeutic-targets-of-the-beta-amyloid-pathway-to-slow-the-progression-of-alzheimer-disease

Related Videos

Related Content

Advertisement

November 25th 2024

Real-World Challenges in DMD PMO Treatment

Hayden E. Klein

A claims-based study revealed high adherence to phosphorodiamidate morpholino oligomer (PMO) treatments for Duchenne muscular dystrophy (DMD), but highlights limitations in interpreting real-world effectiveness from claims data.

November 21st 2024

Frameworks for Advancing Health Equity: Wellness Way

Giuliana Grossi

The Wellness Way facility was designed to improve access to comprehensive outpatient care and address social determinants of health for a diverse patient population.

November 25th 2024

FDA Advised to Update Labels on GLP-1 Weight-Loss Drugs

Maggie L. Shaw

In the US, liraglutide, semaglutide, and tirzepatide are currently under investigation for their ability to stimulate weight loss, with their safety and efficacy primary outcomes of interest.

October 29th 2024

Breaking the Cycle: The Importance of Early Intervention in Hidradenitis Suppurativa

Giuliana Grossi

Prompt care supports mental well-being, as hidradenitis suppurativa is often associated with depression and anxiety due to its physical and social challenges.

November 25th 2024

Racial, Ethnic Disparities Persist in Mortality for Patients With Early-Onset CRC

Julia Bonavitacola

Native Hawaiian and non-Hispanic Black individuals had the highest burden of mortality among patients with early-onset colorectal cancer (CRC).

November 24th 2024

Low RSV Vaccination Rates in Nursing Homes Highlight Urgent Need for Uptake

Pearl Steinzor

Significant gaps in vaccination coverage among nursing home residents leaves vulnerable populations at risk for severe complications, report finds.

Related Content

Advertisement

November 25th 2024

Real-World Challenges in DMD PMO Treatment

Hayden E. Klein

A claims-based study revealed high adherence to phosphorodiamidate morpholino oligomer (PMO) treatments for Duchenne muscular dystrophy (DMD), but highlights limitations in interpreting real-world effectiveness from claims data.

November 21st 2024

Frameworks for Advancing Health Equity: Wellness Way

Giuliana Grossi

The Wellness Way facility was designed to improve access to comprehensive outpatient care and address social determinants of health for a diverse patient population.

November 25th 2024

FDA Advised to Update Labels on GLP-1 Weight-Loss Drugs

Maggie L. Shaw

In the US, liraglutide, semaglutide, and tirzepatide are currently under investigation for their ability to stimulate weight loss, with their safety and efficacy primary outcomes of interest.

October 29th 2024

Breaking the Cycle: The Importance of Early Intervention in Hidradenitis Suppurativa

Giuliana Grossi

Prompt care supports mental well-being, as hidradenitis suppurativa is often associated with depression and anxiety due to its physical and social challenges.

November 25th 2024

Racial, Ethnic Disparities Persist in Mortality for Patients With Early-Onset CRC

Julia Bonavitacola

Native Hawaiian and non-Hispanic Black individuals had the highest burden of mortality among patients with early-onset colorectal cancer (CRC).

November 24th 2024

Low RSV Vaccination Rates in Nursing Homes Highlight Urgent Need for Uptake

Pearl Steinzor

Significant gaps in vaccination coverage among nursing home residents leaves vulnerable populations at risk for severe complications, report finds.